What is the price target for ICAD stock?
23 analysts have analysed ICAD.PA and the average price target is 22.17 EUR. This implies a price increase of 16.44% is expected in the next year compared to the current price of 19.04.
EPA:ICAD • FR0000035081
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ICADE (ICAD.PA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-30 | BNP PARIBAS EXANE | Maintains | Outperform -> Outperform |
| 2023-06-06 | BNP PARIBAS EXANE | Upgrade | Neutral -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.657B -8.74% | 1.572B -5.13% | 1.45B -7.78% | 337.58M -76.71% | 326.7M -3.22% | 357.29M 9.36% | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | 375.2M -43.39% | 318.6M -15.09% | N/A -3.01% | 292.95M -5.20% | 283.58M -3.20% | 300.7M 6.04% | 274.36M -8.76% | 286.69M 4.49% | 296.97M 3.59% | 349.08M 17.55% | |
| EBIT YoY % growth | 256.7M -59.15% | 211.7M -17.53% | 276.4M 30.56% | 245.67M -11.12% | 261.95M 6.63% | 312.03M 19.12% | N/A | N/A | N/A | N/A | |
| Operating Margin | 15.49% | 13.47% | 19.07% | 72.77% | 80.18% | 87.33% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 2.82 -44.05% | 3.16 12.06% | 2.97 -6.01% | 3.05 2.69% | 2.88 -5.67% | 2.84 -1.35% | N/A | N/A | N/A | N/A |
All data in EUR
| Q2 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 1.15 -21.59% | 1.26 -15.68% |
| Revenue Q2Q % growth | N/A | N/A |
| EBITDA Q2Q % growth | 124.83M | 135.61M 2.72% |
| EBIT Q2Q % growth | 115.85M -14.88% | 126.64M -9.74% |
All data in EUR
23 analysts have analysed ICAD.PA and the average price target is 22.17 EUR. This implies a price increase of 16.44% is expected in the next year compared to the current price of 19.04.
ICADE (ICAD.PA) will report earnings on 2026-04-16.
The number of analysts covering ICADE (ICAD.PA) is 23.